Premium quality & industry-leading innovation in drugs of abuse tests

Innovative R&D combined with U.S. manufacturing capabilities, and competitive pricing give our clients a competitive advantage in the ever-evolving drug testing market. Private labelling and co-branding are available for strategic distribution partnerships.

Learn More

Scientifically Innovative Drug Tests

Advin Biotech integrates cutting-edge scientific research to drive innovation. Our key innovations include:

iSplit Cup

iSplit Cup

A removable vessel within the cup collects and retains a pristine specimen for confirmation testing or regulatory compliant storage.



A version of the iSplit Cup that reduces accessioning time in the lab by integrating a removable specimen tube that can go directly into a liquid handler.

1 second dipcard

1 second dipcard

Newly engineered and patented dipcard design to improve speed and efficiency for batch testing multiple specimens.



Proprietary equipment to automate manufacturing steps are designed and built in-house.

The Advin Advantage

  • Innovative


    We deliver novel, cutting -edge solutions to improve testing efficiency in the diverse toxicology market.

  • Made in the U.S.A.

    Made in the U.S.A.

    Our drugs of abuse tests are manufactured in the U.S., ensuring fast delivery and premium quality.

  • Quality and Consistency

    Quality and Consistency

    Our FDA registered IVD manufacturing facility complete with proprietary automated manufacturing processes ensure consistent batch to batch quality of all our product lines.

  • Cost Effective

    Cost Effective

    We provide tailored pricing solutions based on the needs of our clients.

  • Customizable


    All products may be privately labelled for our valued distribution partners and customized cut-off levels are available to meet your unique requirements.

  • On-demand Technical Support

    On-demand Technical Support

    In-house toxicologists are ready to help troubleshoot or answer questions.

A Wide Range

Our products test for all of the most popular drugs of abuse in a variety of combinations including all standard assays, as well as tests for EtG, Tramadol, Fentanyl, Ketamine, and the first US FDA cleared 6AM test. Our CLIA-waived and FDA-approved tests are customizable, to meet a wide range of cutoff levels and we keep pace with fast-paced industry needs by regularly introducing novel drug tests.


  • How accurate are the diagnostic results?

    Most tests are U.S. FDA cleared to be 99.9% accurate, as well as CLIA waived and approved for home use, certifying that they are sufficiently simple to operate and interpret. Any test we make that could be considered a niche test, for which the FDA has not yet established guidelines, is held to this same standard and will be cleared after protocols are established by the FDA.

  • How fast can the results be read?

    Negative results may be seen in as little as one minute. Positive results may be read after 5 minutes. Results should not be read after 60 minutes.

  • Are specific drugs more common than others to provide inaccurate results, based on multiple drugs interacting?

    Some tests do not distinguish between therapeutic use of a drug and abuse of the same drug. A test may yield preliminary positive results when prescription tricyclic antidepressants, barbiturates, benzodiazepines, methadone, buprenorphine or opiates are ingested, even at therapeutic doses. There are no uniformly recognized drug levels for these prescription drugs in urine.

  • How should the tests be stored and for how long?

    Room temperature storage, or 2-30 degrees Celsius / 35.6-86 degrees Fahrenheit is recommended. Do not freeze the test. The expiration date is written on the pouch that contains the device, and the shelf life is 2 years from the date of manufacture.